Target Name: MIR3171
NCBI ID: G100422830
Other Name(s): hsa-mir-3171 | MicroRNA 3171 | hsa-miR-3171 | microRNA 3171

MIR3171: A Drug Target / Disease Biomarker

MIR3171, also known as interleukin-31 (IL-31), is a protein that is expressed in various tissues throughout the body, including the lungs, heart, kidneys, and intestines. It is a member of the interleukin family, which is a group of cytokines that play a crucial role in the immune system and other physiological processes.

One of the things that makes MIR3171 an interesting drug target is its role in the regulation of inflammation. MIR3171 has been shown to play a key role in the recruitment of immune cells to the site of inflammation, as well as in the production of pro-inflammatory cytokines. This makes it an attractive target for drugs that are designed to alleviate inflammation and promote tissue repair.

In addition to its role in inflammation, MIR3171 has also been shown to be involved in a number of other cellular processes that are important for maintaining tissue health and function. For example, it has been shown to promote the growth and survival of epithelial cells, which are the cells that line the lining of various body surfaces and organs. It has also been shown to play a key role in the regulation of cell signaling pathways, which are the mechanisms that cells use to communicate with one another and coordinate their activities.

Despite the potential benefits of MIR3171 as a drug target, there are also several concerns about its safety and effectiveness. For example, there is some evidence to suggest that high levels of MIR3171 may be associated with the development of certain diseases, such as cancer and autoimmune disorders. Additionally, the effects of MIR3171 may be different in different animal models, which can make it difficult to predict its safety and effectiveness in humans.

Despite these concerns, MIR3171 is still an attractive drug target for researchers because of its ability to modulate a wide range of cellular processes that are important for maintaining tissue health and function. The development of MIR3171-based therapies could have a significant impact on the treatment of a wide range of diseases, including cancer, autoimmune disorders, and other inflammatory conditions.

Protein Name: MicroRNA 3171

More Common Targets

MIR3171HG | MIR3173 | MIR3174 | MIR3175 | MIR3176 | MIR3177 | MIR3178 | MIR3179-1 | MIR3179-2 | MIR3179-3 | MIR3180-1 | MIR3180-2 | MIR3180-3 | MIR3180-4 | MIR3180-5 | MIR3182 | MIR3183 | MIR3184 | MIR3185 | MIR3186 | MIR3187 | MIR3188 | MIR3189 | MIR3190 | MIR3191 | MIR3192 | MIR3193 | MIR3194 | MIR3195 | MIR3196 | MIR3197 | MIR3198-1 | MIR3199-1 | MIR3199-2 | MIR31HG | MIR32 | MIR3200 | MIR3201 | MIR3202-1 | MIR3202-2 | MIR320A | MIR320B1 | MIR320B2 | MIR320C1 | MIR320C2 | MIR320D1 | MIR320D2 | MIR320E | MIR323A | MIR323B | MIR324 | MIR325 | MIR325HG | MIR326 | MIR328 | MIR329-1 | MIR329-2 | MIR330 | MIR331 | MIR335 | MIR337 | MIR338 | MIR339 | MIR33A | MIR33B | MIR340 | MIR342 | MIR345 | MIR346 | MIR34A | MIR34AHG | MIR34B | MIR34C | MIR3529 | MIR3591 | MIR3605 | MIR3606 | MIR3609 | MIR361 | MIR3610 | MIR3611 | MIR3612 | MIR3613 | MIR3614 | MIR3615 | MIR3616 | MIR3617 | MIR3618 | MIR3619 | MIR362 | MIR3620 | MIR3621 | MIR3622A | MIR3622B | MIR363 | MIR3646 | MIR3648-1 | MIR3649 | MIR3650 | MIR3651